🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China flag China · Delayed Price · Currency is CNY
37.47
-0.68 (-1.78%)
Nov 20, 2026, 3:00 PM CST

SHA:600329 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,3141,0162,9442,1252,8832,283
Short-Term Investments
436.13,3161,00061.740.61109.64
Cash & Short-Term Investments
1,7514,3323,9452,1872,9232,393
Cash Growth
0.96%9.84%80.37%-25.19%22.16%20.40%
Accounts Receivable
1,4251,5711,3162,6532,7251,971
Other Receivables
83.410.298.5634.160.7740.73
Receivables
1,5091,6051,3252,6872,7852,011
Inventory
1,1411,1331,2861,5671,4291,525
Other Current Assets
39.2484.5752.96111.07107.5495.77
Total Current Assets
4,4397,1556,6086,5527,2456,425
Property, Plant & Equipment
1,1161,1411,3931,4421,4651,486
Long-Term Investments
2,3722,5932,065882.67801.46740.74
Goodwill
--12.365.9184.69-
Other Intangible Assets
316.68292.75295.29317.75281.13198.19
Long-Term Deferred Tax Assets
331.46341.01314.4265.99208.35154.6
Long-Term Deferred Charges
-52.8366.0718.317.544.72
Other Long-Term Assets
158.64114.3313.56686.2953.7757.51
Total Assets
8,73411,69010,76910,23010,1579,067

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
207.58189.19233.741,1261,4061,242
Accrued Expenses
313.641,9171,8241,4931,170679.77
Short-Term Debt
86.0357.921.6581.8101.64-
Current Portion of Long-Term Debt
-----30
Current Portion of Leases
4.093.121.333.564.11.6
Current Income Taxes Payable
33.7329.22297.5776.6893.289.53
Current Unearned Revenue
-150.19123.56145.66219.07215.61
Other Current Liabilities
1,7892,160315.64305.66339.37254.89
Total Current Liabilities
2,4344,5062,8183,2333,3332,434
Long-Term Debt
-1010251.03161.310
Long-Term Leases
4.84.665.62.740.871.57
Long-Term Unearned Revenue
-45.4955.1457.1459.8859.15
Long-Term Deferred Tax Liabilities
0.180.286.047.338.824.21
Other Long-Term Liabilities
83.7222.9324.0733.6940.7344.42
Total Liabilities
2,5234,5902,9193,5853,6052,553

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
770.09770.09770.09770.16773.44773.44
Additional Paid-In Capital
1,207974.98974.79975.211,0481,374
Retained Earnings
4,2385,3306,0724,8284,7004,218
Treasury Stock
----7.04-29.75-32.03
Comprehensive Income & Other
-24.0726.9334.3429.5330.62
Total Common Equity
6,2157,0997,8446,6016,5216,364
Minority Interest
-3.650.456.3444.5530.49149.35
Shareholders' Equity
6,2117,1007,8506,6456,5526,514
Total Liabilities & Equity
8,73411,69010,76910,23010,1579,067

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
94.9175.6838.59339.14267.9143.17
Net Cash (Debt)
1,6564,2573,9061,8482,6552,350
Net Cash Growth
-3.37%8.98%111.39%-30.41%13.01%20.83%
Net Cash Per Share
2.155.535.062.403.423.05
Filing Date Shares Outstanding
770.09770.09770.09770.16773.44773.44
Total Common Shares Outstanding
770.09770.09770.09770.16773.44773.44
Working Capital
2,0052,6483,7903,3193,9123,991
Book Value Per Share
8.079.2210.198.578.438.23
Tangible Book Value
5,8986,8077,5366,2176,1566,166
Tangible Book Value Per Share
7.668.849.798.077.967.97
Buildings
-1,0991,3251,3381,3371,323
Machinery
-1,0481,0661,1071,0871,028
Construction In Progress
-391.01436.35386.46333.85331.62